CAR cell design strategies in solid tumors

被引：2
作者：
Wang, Lu [1 ]
Chen, Xinyi [1 ]
Zhang, Lu [1 ]
Niu, Boning [2 ]
Li, Long [1 ]
Sun, Yinan [3 ]
Yuan, Xianglin [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Jie Fang Rd 1095, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Hangkong Rd 13, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiol, Jie Fang Rd 1095, Wuhan, Hubei, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2022年 / 113卷
关键词：
Chimeric antigen receptor; Design strategy; Solid tumors; Cytokine release syndrome; DELTA T-CELLS; CANCER; THERAPY; IMMUNOTHERAPY; RECEPTORS; RECOGNITION; CYTOKINE; FUTURE;
D O I：
10.1016/j.intimp.2022.109345
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In addition to chimeric antigen receptor (CAR)-alpha beta T-cell therapy, CAR-NK, CAR-NKT, CAR-M and CAR-gamma delta T-cell therapy have gradually been applied to the treatment of solid tumors. Compared to hematological tumors, solid tumors have the characteristics of strong tumor heterogeneity, limited target antigen selection, and low T-cell infiltration to build immunosuppressive tumor microenvironment. These features would present great obstacles to CAR cell therapy. This paper comprehensively analyzed the application of different CAR cells to solid tumors and summarized the design principles of different CAR cells to provide the direction for the development of CAR cell therapy in solid tumors.
引用
收藏
页数：9
相关论文
共 112 条
  • [1] Macrophage-Based Approaches for Cancer Immunotherapy
    Anderson, Nicholas R.
    Minutolo, Nicholas G.
    Gill, Saar
    Klichinsky, Michael
    [J]. CANCER RESEARCH, 2021, 81 (05) : 1201 - 1208
  • [2] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
    Berdeja, Jesus G.
    Madduri, Deepu
    Usmani, Saad Z.
    Jakubowiak, Andrzej
    Agha, Mounzer
    Cohen, Adam D.
    Stewart, A. Keith
    Hari, Parameswaran
    Htut, Myo
    Lesokhin, Alexander
    Deol, Abhinav
    Munshi, Nikhil C.
    O'Donnell, Elizabeth
    Avigan, David
    Singh, Indrajeet
    Zudaire, Enrique
    Yeh, Tzu-Min
    Allred, Alicia J.
    Olyslager, Yunsi
    Banerjee, Arnob
    Jackson, Carolyn C.
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Deraedt, William
    Zhuang, Sen Hong
    Infante, Jeffrey
    Geng, Dong
    Wu, Xiaoling
    Carrasco-Alfonso, Marlene J.
    Akram, Muhammad
    Hossain, Farah
    Rizvi, Syed
    Fan, Frank
    Lin, Yi
    Martin, Thomas
    Jagannath, Sundar
    [J]. LANCET, 2021, 398 (10297) : 314 - 324
  • [3] Borghaei H, 2021, J CLIN ONCOL, V39, P723, DOI 10.1200/JCO.20.01605
  • [4] Diversity of γδ T-cell antigens
    Born, Willi K.
    Aydintug, M. Kemal
    O'Brien, Rebecca L.
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (01) : 13 - 20
  • [5] The Identity of Human Tissue-Emigrant CD8+ T Cells
    Buggert, Marcus
    Vella, Laura A.
    Nguyen, Son
    Wu, Vincent H.
    Chen, Zeyu
    Sekine, Takuya
    Perez-Potti, Andre
    Maldini, Colby R.
    Manne, Sasikanth
    Darko, Samuel
    Ransier, Amy
    Kuri-Cervantes, Leticia
    Japp, Alberto Sada
    Brody, Irene Bukh
    Ivarsson, Martin A.
    Gorin, Jean-Baptiste
    Rivera-Ballesteros, Olga
    Hertwig, Laura
    Antel, Jack P.
    Johnson, Matthew E.
    Okoye, Afam
    Picker, Louis
    Vahedi, Golnaz
    Sparrelid, Ernesto
    Llewellyn-Lacey, Sian
    Gostick, Emma
    Sandberg, Johan K.
    Bjorkstrom, Niklas
    Bar-Or, Amit
    Dori, Yoav
    Naji, Ali
    Canaday, David H.
    Laufer, Terri M.
    Wells, Andrew D.
    Price, David A.
    Frank, Ian
    Douek, Daniel C.
    Wherry, E. John
    Itkin, Maxim G.
    Betts, Michael R.
    [J]. CELL, 2020, 183 (07) : 1946 - +
  • [6] CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
    Burger, Michael C.
    Zhang, Congcong
    Harter, Patrick N.
    Romanski, Annette
    Strassheimer, Florian
    Senft, Christian
    Tonn, Torsten
    Steinbach, Joachim P.
    Wels, Winfried S.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [7] Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer
    Burns, LJ
    Weisdorf, DJ
    DeFor, TE
    Repka, TL
    Ogle, KM
    Hummer, C
    Miller, JS
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) : 96 - 103
  • [8] Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial
    Caballero, Iraida
    Aira, Lazaro E.
    Lavastida, Anabel
    Popa, Xitlally
    Rivero, Javier
    Gonzalez, Joaqun
    Mesa, Monica
    Gonzalez, Narjara
    Coba, Kelly
    Lorenzo-Luaces, Patricia
    Wilkinson, Barbara
    Santiesteban, Yuliannis
    Santiesteban, Yanela
    Troche, Mayelin
    Suarez, Eduardo
    Crombet, Tania
    Sanchez, Belinda
    Casaco, Angel
    Macias, Amparo
    Mazorra, Zaima
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [9] Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
    Capsomidis, Anna
    Benthall, Gabriel
    Van Acker, Heleen H.
    Fisher, Jonathan
    Kramer, Anne M.
    Abeln, Zarah
    Majani, Yvonne
    Gileadi, Talia
    Wallace, Rebecca
    Gustafsson, Kenth
    Flutter, Barry
    Anderson, John
    [J]. MOLECULAR THERAPY, 2018, 26 (02) : 354 - 365
  • [10] γδ T cell Receptor Ligands and Modes of Antigen Recognition
    Champagne, Eric
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2011, 59 (02) : 117 - 137
12345678910